GGrantScoutHQCreate alert

Curated topic

Community Grants for Local Governments — Page 7

Place-based opportunities listing county, city, township or special-district applicants.

249 current opportunities · showing 145–168

OPENHealth & Medical

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

National Institutes of Health

The goal of this funding opportunity announcement (FOA) is to fund meritorious vision-related research projects that involve secondary data analyses using existing database resources. The development of statistical methodology necessary for improving methods to analyze vision health data using exist

Deadline
Oct 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

National Institutes of Health

The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting well designed and well executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and

Deadline
Oct 19, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a si

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall und

Deadline
Oct 21, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of I

Deadline
Oct 21, 2027
Funding
Estimated total program funding: $750,000
Check fit and official source →
OPENHealth & Medical

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

National Institutes of Health

Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (A

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

National Institutes of Health

Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

National Institutes of Health

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

National Institutes of Health

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive

Deadline
Oct 26, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were

Deadline
Nov 6, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

National Institutes of Health

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and be

Deadline
Nov 6, 2027
Funding
Up to $1,500,000
Check fit and official source →
OPENHealth & Medical

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

National Institutes of Health

The Theories, Models and Methods (TMM) initiative will support the development of computational tools for understanding dynamic brain circuits that are made broadly accessible to the greater research community. This program supports applications focused on tool building and dissemination in the doma

Deadline
Nov 9, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

National Institutes of Health

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an e

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

National Institutes of Health

The objective of the NIA Academic Leadership Career Award (K07) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD)research capacity within their academi

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

National Institutes of Health

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an e

Deadline
Nov 13, 2027
Funding
See official notice
Check fit and official source →
OPENDisability & Accessibility

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observ

Deadline
Nov 16, 2027
Funding
Up to $6,250,000
Check fit and official source →
OPENHealth & Medical

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics

Deadline
Nov 16, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

National Institutes of Health

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may b

Deadline
Nov 17, 2027
Funding
Estimated total program funding: $200,000
Check fit and official source →
OPENHealth & Medical

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biolo

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins i

Deadline
Nov 17, 2027
Funding
Up to $100,000
Check fit and official source →
OPENHealth & Medical

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

National Institutes of Health

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may b

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR)

Deadline
Nov 17, 2027
Funding
See official notice
Check fit and official source →
OPENResearch & Science

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support

Deadline
Nov 19, 2027
Funding
Estimated total program funding: $300,000
Check fit and official source →
OPENHealth & Medical

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this Notice of Opportunity Announcement (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescri

Deadline
Dec 4, 2027
Funding
See official notice
Check fit and official source →

Strong fit signals

  • The public need is documented
  • The jurisdiction can accept the award
  • Implementation ownership is clear

Requirements to verify

  • Population or geography thresholds
  • Maintenance and long-term operating costs

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this community grants for local governments page?

Local governments and special districts. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.